课题基金 / 基金详情

DRUG-INDUCED PARKINSONIAN SYMPTOMS IN THE ELDERLY

DRUG-INDUCED PARKINSONIAN SYMPTOMS IN THE ELDERLY
老年人药物引起的帕金森病症状
批准号:
3121537
负责人:
JEROME L AVORN
金额:
$7.82万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-02-01 至 1993-01-31

项目摘要

项目成果

JEROME L AVORN的其他基金

相似基金

相关文献

中文摘要
翻译
帕金森氏症的症状可导致严重的发病率,包括跌倒和 骨折、自理能力下降和早产 制度化。关于药物产生的频率,我们知之甚少 使用抗精神病药后出现诱发性帕金森症状(DIP) (抗精神病药物)药物。这个问题因为年龄的原因而令人担忧-- 相关的多巴胺能功能下降,大量使用神经抗精神病药 老年人,以及高血压与特发性高血压的潜在混淆 帕金森氏症,导致误诊和治疗 额外的药物。DIP代表了一种更频繁的和 潜在地禁用衰老过程中的不良药物影响,这是可以有针对性的 如果更多的人了解它的流行情况和 相关的风险因素。 拟议的项目是利用数据库进行的流行病学研究。 由研究团队开发,包含所有报销的医疗保健 新泽西州所有医疗补助人口从1980年到 1988年,补充了所有参与者的完整索赔历史 该州的老年人和残疾人药房援助(PAAD)计划, 以及新泽西州联邦医疗保险(A部分和B部分)的索赔文件 同一时期。病例对照设计将确定所有新的收件人 通常用于治疗帕金森氏症症状的药物,以及 被诊断为帕金森氏症的受赠者。控制将是 从相同的医疗补助受助人群体中抽取。相对的 以前使用特定抗精神病药物的频率将被测量 在病例和对照中,使用两个相关的 药物,甲氧氯普胺和丙氯丙嗪。 这项研究将产生确定风险增加的赔率比 服用特定抗精神病药物的患者出现帕金森症状的可能性 与没有接受这些药物的患者相关的药物。全 分析将按年龄、性别、在养老院居住和 按医疗补助资格期间的医疗补助处方药申请数量。 不同常用的抗精神病药物之间的风险差异将是 定义以及年龄、剂量和使用持续时间作为效果的作用 修饰符。卫生服务研究问题也将被研究, 包括对处方医生和医疗保健环境的描述 高下降率。
英文摘要
Parkinsonian symptoms can cause substantial morbidity, including falls and fractures, decline in capacity for self-care, and premature institutionalization. Little is known about the frequency with which drug- induced parkinsonian symptoms (DIPS) occur following use of neuroleptic (anti-psychotic) medication. This problem is of concern because of age- related decrease in dopaminergic function, the heavy use of neuroleptics in the elderly, and the potential confusion of DIPS with idiopathic Parkinson's disease, leading to erroneous diagnosis and treatment with an additional medication. DIPS represents one of the more frequent and potentially disabling adverse drug effects in aging which could be targeted for educational intervention if more were known about its prevalence and associated risk factors. The proposed project is an epidemiologic study making use of a database developed by the study team that contains all reimbursed health care encounters for the entire Medicaid population of New Jersey from 1980 to 1988, supplemented by the complete claims histories of all participants in the state's Pharmacy Assistance for the Aged and Disabled (PAAD) program, and the claims file for Medicare (Parts A and B) for New Jersey for the same period. A case-control design will identify all new recipients of medications commonly used to treat parkinsonian symptoms, as well as all recipients diagnosed as having parkinsonian symptoms. Controls will be drawn from the same population of Medicaid recipients. The relative frequency of prior use of specific neuroleptic agents will be measured among cases and controls, as will the frequency of use of two related drugs, metoclopramide and prochlorperazine. The study will generate odds ratios that will identify the increase in risk of developing parkinsonian symptoms in patients given specific neuroleptic medications relative to patients who do not receive these agents. All analyses will be stratified by age, gender, residence in nursing homes, and by numbers of Medicaid prescription claims during Medicaid eligibility. Differences in risk among the various commonly used neuroleptics will be defined as well as the role of age, dose, and duration of use as effect modifiers. Health services research questions will also be studied, including characterization of prescribers and health-care settings with high rates of DIPS.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people.
老年人的抗精神病药处方模式和锥体外系症状的治疗。
DOI: 10.1111/j.1532-5415.1995.tb05559.x
发表时间: 1995
期刊: Journal of the American Geriatrics Society
影响因子: 6.3
作者: [Kalish,SC, Bohn,RL, Mogun,H, Glynn,RJ, Gurwitz,JH, Avorn,J]
通讯作者: Avorn,J
DRUGS AND AGING--DEMOGRAPHIC, CLINICAL, AND COST DATA
  • 批准号:
    6190122
  • 项目类别:
  • 资助金额:
    $8.48万
  • 财政年份:
    2000
  • 负责人:
    JEROME L AVORN
  • 依托单位:
RISKY GERIATRIC BENZODIAZEPINE USE--PREDICTORS & TRENDS
  • 批准号:
    2488631
  • 项目类别:
  • 资助金额:
    $4.14万
  • 财政年份:
    1996
  • 负责人:
    JEROME L AVORN
  • 依托单位:
RISKY GERIATRIC BENZODIAZEPINE USE--PREDICTORS & TRENDS
  • 批准号:
    2517966
  • 项目类别:
  • 资助金额:
    $26.94万
  • 财政年份:
    1996
  • 负责人:
    JEROME L AVORN
  • 依托单位:
RISKY GERIATRIC BENZODIAZEPINE USE--PREDICTORS & TRENDS
  • 批准号:
    2013418
  • 项目类别:
  • 资助金额:
    $24.16万
  • 财政年份:
    1996
  • 负责人:
    JEROME L AVORN
  • 依托单位:
海外基金